DNM1L and neurodegenerative disease: Another Drp1 inhibitor, p110, blocks the recruitment of Drp1 by Fis1, thereby inhibiting Drp1 translocation to the outer mitochondrial membrane, leading to mitochondrial fragmentation and massive ROS production, which in turn affects apoptosis and cell viability, and is mainly used in neurodegenerative diseases (119).